本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Milestone Pharmaceuticals Inc.

1.16
+0.120011.54%
盤前1.170.0100+0.86%04:01 EDT
成交量:170.93萬
成交額:193.26萬
市值:1.44億
市盈率:-1.72
高:1.17
開:1.06
低:1.05
收:1.04
52周最高:3.06
52周最低:1.00
股本:1.24億
流通股本:1.06億
量比:0.90
換手率:1.61%
股息:- -
股息率:- -
每股收益(TTM):-0.6748
每股收益(LYR):-0.7517
淨資產收益率:-35522.62%
總資產收益率:-42.78%
市淨率:7.90
市盈率(LYR):-1.54

資料載入中...

2023/03/07

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/10

重要事件披露

8-K - Current report
2022/10/31

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/24

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/17

重要事件披露

8-K - Current report
2022/09/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/10

重要事件披露

8-K - Current report
2022/07/08

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans